Valuation: SMAIO

Market Cap 3.75Cr 4.22Cr 3.5Cr 3.19Cr 6.02Cr 405.88Cr 6.07Cr 42Cr 16Cr 207.49Cr 16Cr 16Cr 665.91Cr P/E 2026 *
-17.1x
P/E 2027 * 167x
Enterprise Value 3.6Cr 4.05Cr 3.36Cr 3.06Cr 5.78Cr 389.65Cr 5.83Cr 41Cr 16Cr 199.19Cr 15Cr 15Cr 639.28Cr EV / Sales 2026 *
3.27x
EV / Sales 2027 * 2.29x
Free-Float
14.95%
Yield 2026 *
-
Yield 2027 * -
1 day-1.48%
1 week-6.46%
Current month-1.48%
1 month-11.90%
3 months-19.76%
6 months-7.50%
Current year+6.56%
1 week 6.54
Extreme 6.54
7.52
1 month 6.16
Extreme 6.16
7.66
Current year 6
Extreme 6
9.1
1 year 5.9
Extreme 5.9
9.1
3 years 2.25
Extreme 2.25
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 29/12/2008
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2020
Director TitleAgeSince
Chairman - 30/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.48%-6.46%-2.77%+158.14% 4.22Cr
-0.61%-3.43%+39.40%+112.31% 1,01900Cr
-1.02%-5.60%+37.67%+65.02% 62TCr
+1.11%-0.58%+11.10%+77.28% 46TCr
+0.34%-3.01%+61.21%+40.71% 36TCr
-0.95%-4.05%+21.60%+39.37% 33TCr
-1.46%-2.89%+11.84%+24.60% 27TCr
-1.35%-5.43%-4.69%+8.40% 24TCr
-1.04%-2.79%+35.52%+51.34% 22TCr
-1.87%-4.10%+30.92%+95.33% 18TCr
Average -0.36%-3.70%+24.18%+67.25% 36.97TCr
Weighted average by Cap. +0.42%-3.33%+30.52%+68.96%

Financials

2026 *2027 *
Net sales 1.1Cr 1.24Cr 1.03Cr 93.58L 1.76Cr 119.02Cr 1.78Cr 12Cr 4.81Cr 61Cr 4.65Cr 4.55Cr 195.27Cr 1.6Cr 1.8Cr 1.49Cr 1.36Cr 2.57Cr 173.11Cr 2.59Cr 18Cr 7Cr 88Cr 6.76Cr 6.61Cr 284.02Cr
Net income -22.5L -25.32L -21L -19.14L -36.1L -24Cr -36.44L -2.54Cr -98.48L -12Cr -95.08L -93.01L -40Cr 2L 3L 2L 2L 4L 2.7Cr 4L 28.24L 10.94L 1.38Cr 10.56L 10.33L 4.44Cr
Net Debt -15L -16.88L -14L -12.76L -24.07L -16Cr -24.29L -1.69Cr -65.65L -8.3Cr -63.38L -62.01L -27Cr -9L -10.13L -8L -8L -14.44L -9.74Cr -14.57L -1.02Cr -39.39L -4.98Cr -38.03L -37.21L -16Cr
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
02/26/02 €6.660 -1.48% 26
01/26/01 €6.760 0.00% 2
30/26/30 €6.760 -0.59% 1,137
29/26/29 €6.800 -0.29% 776
28/26/28 €6.820 -4.21% 1,177
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.660EUR
Average target price
8.200EUR
Spread / Average Target
+23.12%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock